Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
Annalisa Comandatore, Benoît Immordino, Rita Balsano, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 286-286
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells
Cecilia Bergonzini, Alessandro Gregori, Tessa M. S. Hagens, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 16
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes
Katherine Richards, Weikun Xiao, Reginald Hill
Cancers (2022) Vol. 14, Iss. 11, pp. 2812-2812
Open Access | Times Cited: 43
Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities
Madita Wandrey, Jadwiga Jabłońska, Roland H. Stauber, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2033-2033
Open Access | Times Cited: 25
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer
Rohit Sarkar, Zhihong Xu, Chamini J. Perera, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 114-122
Open Access | Times Cited: 19
Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
Md Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2000-2000
Open Access | Times Cited: 14
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
Mahrou Vahabi, Bilal Dehni, Inés Antomás, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 725-740
Open Access | Times Cited: 12
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism
Mahrou Vahabi, Annalisa Comandatore, Marika Frańczak, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 163-172
Open Access | Times Cited: 12
microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
Naotake Funamizu, Masahiko Honjo, Kei Tamura, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1230-1230
Open Access | Times Cited: 11
The Multifaceted Role of miR-21 in Pancreatic Cancers
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi
Cells (2024) Vol. 13, Iss. 11, pp. 948-948
Open Access | Times Cited: 4
miR-378d suppresses gastric cancer metastasis by targeting METTL4 to inhibit epithelial-mesenchymal transition
Dajun Xing, Jiapeng Bao, Jiancheng He, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
α-Fodrin–CENP-E interaction is critical for pancreatic cancer progression and drug response
Athira Jyothy, Jamshad Hussain, C. S. Sharanya, et al.
Cell Cycle (2025), pp. 1-25
Closed Access
Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
Stavros P. Papadakos, Nikolaos Dedes, Alexandros Pergaris, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3620-3620
Open Access | Times Cited: 18
Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery
Mohammad Imran Khan, Reem Khaled M.E. Alsayed, Hani Choudhry, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6222-6222
Open Access | Times Cited: 16
Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells
Florian Draguet, Nathan Dubois, C Bouland, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2901-2901
Open Access | Times Cited: 10
Recent Trends in Nanomaterial Based Electrochemical Sensors for Drug Detection: Considering Green Assessment
Tuğba Özer, Charles S. Henry
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 11, pp. 952-972
Closed Access | Times Cited: 3
Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, et al.
Advances in cancer research (2023), pp. 285-341
Closed Access | Times Cited: 8
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism
Federica Anastasi, Asia Botto, Benoît Immordino, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 3-19
Closed Access | Times Cited: 6
Genomic and epigenetic characterization of the arsenic-induced oncogenic microRNA-21
Haoyan Ji, Zhuoyue Bi, Aashna S. Pawar, et al.
Environmental Pollution (2024) Vol. 345, pp. 123396-123396
Open Access | Times Cited: 2
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer
Mahrou Vahabi, Annalisa Comandatore, Chiara Centra, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 50-67
Open Access | Times Cited: 6
A 3D Pancreatic Cancer Model with Integrated Optical Sensors for Noninvasive Metabolism Monitoring and Drug Screening
Anna Chiara Siciliano, Stefania Forciniti, Valentina Onesto, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 1
Novel insight and perspectives of nanoparticle-mediated gene delivery and immune-modulating therapies for pancreatic cancer
Xinqiao Wang, Xue Qiong Yin, Yuxin Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Overcoming the Limitations of Therapeutic Strategies to Combat Pancreatic Cancer using Nanotechnology
Shivang Dhoundiyal, Md. Aftab Alam
Current Cancer Drug Targets (2023) Vol. 23, Iss. 9, pp. 697-717
Closed Access | Times Cited: 2
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
Luigi Sapio, Angela Ragone, Annamaria Spina, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 625-36
Open Access | Times Cited: 4
Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review
Jeanne Allard, Mathilde Bonnet, Lucie Laurent, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 7, pp. 1087-1093
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top